H L Tillmann
Overview
Explore the profile of H L Tillmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1035
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wiegand J, Brosteanu O, Kullig U, Wiese M, Berr F, Maier M, et al.
Z Gastroenterol
. 2011 Nov;
49(11):1463-9.
PMID: 22069045
Background: Peginterferon alpha-2b (PEG-IFNa2b) and lamivudine are efficient treatment options for chronic hepatitis B virus (HBV) infection. We assumed that a combination therapy of PEG-IFNα-2b plus lamivudine will be more...
12.
Karlas T, Pfrepper C, Rosendahl J, Benckert C, Wittekind C, Jonas S, et al.
Z Gastroenterol
. 2011 Apr;
49(4):443-8.
PMID: 21476180
Acoustic radiation force Impulse (ARFI) technology correlates shear-wave velocity with fibrosis. It can differentiate between advanced fibrosis and normal tissue in chronic liver disease. However, specificity is impaired by cholestasis,...
13.
Karlas T, Hartmann J, Weimann A, Maier M, Bartels M, Jonas S, et al.
Transpl Infect Dis
. 2010 Dec;
13(3):299-302.
PMID: 21159112
Combination therapy with antivirals plus hepatitis B immunoglobulin (HBIg) has become the standard treatment for prevention of post-liver transplant hepatitis B virus (HBV) recurrence. However, HBIg therapy is inconvenient and...
14.
Bokemeyer M, Ding X, Goldbecker A, Raab P, Heeren M, Arvanitis D, et al.
Gut
. 2010 Oct;
60(3):370-7.
PMID: 20926642
Objective: Fatigue, mood disturbances and cognitive dysfunction are frequent in patients infected with hepatitis C virus (HCV) who have mild liver disease. The reason is still unclear. The present study...
15.
Wiegand J, Karlas T, Schiefke I, Krasselt U, Bock T, Mossner J, et al.
Clin Nephrol
. 2010 Jun;
74(1):53-8.
PMID: 20557867
Therapy of chronic hepatitis B has improved by the invention of the potent nucleos(t)ide analogues entecavir, telbivudine and tenofovir disoproxil. Due to increasing prevalence of lamivudine resistance the appropriate first...
16.
Patel K, Jhaveri R, George J, Qiang G, Kenedi C, Brown K, et al.
J Viral Hepat
. 2010 Apr;
18(5):331-7.
PMID: 20367801
HMG CoA reductase inhibition suppresses in vitro HCV replication through depletion of cellular sterol proteins such as geranylgeraniol. Our aims were to prospectively evaluate the changes in serum and lipid...
17.
Tillmann H, Wiese M, Braun Y, Wiegand J, Tenckhoff S, Mossner J, et al.
J Viral Hepat
. 2010 Mar;
18(4):252-61.
PMID: 20337922
Little is known comparing and contrasting quality of life (QoL) in patients with hepatitis C, compared to patients with other liver diseases. We performed two independent prospective cross-sectional studies including...
18.
Successful liver transplantation in antituberculosis therapy-induced acute fulminant hepatic failure
Schneider R, Bercker S, Schubert S, Tillmann H, Fangmann J, Hauss J, et al.
Transplant Proc
. 2009 Nov;
41(9):3934-6.
PMID: 19917416
The antituberculosis drugs isoniazid, rifampin, and pyrazinamide expose patients to the risk of hepatotoxicity ranging from an asymptomatic increase in aminotransferase concentrations to fulminant hepatic failure. Herein, we report a...
19.
Wiegand J, Meya S, Schlaphoff V, Manns M, Mossner J, Wedemeyer H, et al.
J Viral Hepat
. 2009 Nov;
17(9):631-9.
PMID: 19889141
The hepatitis B virus (HBV) is frequently transmitted by sexual intercourse. Thus, HBV-guidelines recommend vaccination. However, we have identified healthy hepatitis B surface antigen and anti-HBc-negative unvaccinated sexual partners of...
20.
Heidrich B, Deterding K, Tillmann H, Raupach R, Manns M, Wedemeyer H
J Viral Hepat
. 2009 Jul;
16(12):883-94.
PMID: 19566789
Hepatitis D virus (HDV) or delta hepatitis has mainly been studied in Asian and Mediterranean cohorts, but data on virological and clinical characteristics of HDV-infected Central and Northern European patients...